Snapshot from Sep 19, 2026 at 07:00 UTC. For live data and tracking: View Live
Business divestiture

Symrise sells AmeriTerpenes to Mutares

Analysis based on 8 articles · First reported Sep 01, 2026 · Last updated Sep 02, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The divestiture is expected to result in a mid-double-digit million-euro non-cash disposal loss for Symrise, which may weigh on its 2026 earnings but aligns with its portfolio optimization strategy. For Mutares SE & Co. KGaA, the acquisition represents a strategic expansion in the U.S. chemicals market, potentially enhancing its growth prospects.

Chemicals Flavors and Fragrances Private Equity

On September 1, 2026, Symrise AG announced the signing and simultaneous closing of a definitive agreement to sell AmeriTerpenes LLC, its terpene ingredients business, to Mutares SE & Co. KGaA SE & Co. KGaA. The transaction, with undisclosed financial terms, is part of Symrise's ONE Symrise strategy to sharpen its portfolio and focus on core growth platforms. AmeriTerpenes, a producer of renewable terpene ingredients with manufacturing sites in Jacksonville, Florida and Colonels Island, Georgia, will become a new platform investment for Mutares SE & Co. KGaA' Chemicals & Materials segment, strengthening its U.S. footprint. Symrise expects a non-cash disposal loss in the mid-double-digit million-euro range, to be reflected in its 2026 annual financial statements. Symrise and AmeriTerpenes will continue their commercial relationship through supply arrangements. Symrise was advised by Stifel, Alvarez and Marsal, and Troutman Pepper Locke LLP. Symrise shares closed at €92.20 on Monday, down 0.75% on XETRA.

80 Symrise expected non-cash disposal loss
stock
Symrise divests its terpene business to sharpen focus on core growth platforms, incurring a non-cash disposal loss but securing long-term supply agreements.
Importance 100.0 Sentiment 10.0
stock
Mutares SE & Co. KGaA acquires AmeriTerpenes as a new platform investment, strengthening its Chemicals & Materials segment and U.S. presence.
Importance 90.0 Sentiment 70.0
priv
AmeriTerpenes is sold to Mutares SE & Co. KGaA, gaining a new owner focused on developing its renewable terpene portfolio.
Importance 80.0 Sentiment 60.0
per
As CEO of Symrise, Jean-Yves Parisot commented on the strategic rationale for the divestiture.
Importance 40.0 Sentiment 10.0
per
As CIO of Mutares SE & Co. KGaA, Johannes Laumann highlighted the strategic fit of the acquisition.
Importance 40.0 Sentiment 70.0
cnt
The U.S. market is strategically important for Mutares SE & Co. KGaA, and AmeriTerpenes' operations are based there.
Importance 30.0 Sentiment 0.0
cnt
Both Symrise and Mutares SE & Co. KGaA are headquartered in Germany, and the transaction is part of their global strategies.
Importance 20.0 Sentiment 0.0
curr
The disposal loss is reported in euros, reflecting the currency of the companies' financial reporting.
Importance 20.0 Sentiment 0.0
stock
Stifel acted as financial adviser to Symrise in the transaction.
Importance 10.0 Sentiment 0.0
priv
Alvarez and Marsal provided carve-out and vendor due diligence advisory services.
Importance 10.0 Sentiment 0.0
priv
Troutman Pepper Locke LLP served as legal adviser to Symrise.
Importance 10.0 Sentiment 0.0
exch
Mutares SE & Co. KGaA shares are traded on the Frankfurt Stock Exchange, which may see market reaction to the deal.
Importance 10.0 Sentiment 0.0
exch
Symrise shares are traded on XETRA, where the stock closed down 0.75% prior to the announcement.
Importance 10.0 Sentiment 0.0
index
Mutares SE & Co. KGaA is included in the SDAX index, which may be affected by the transaction.
Importance 10.0 Sentiment 0.0
United States strained ally ↔ Germany The United States provides substantial security guarantees to Germany but has recently strained ties by withdrawing troo
United States related ↔ Stifel
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.